January 10th, 2019 – Toronto, ON – Life Sciences Ontario (“LSO”) and BioBenefits are pleased to announce that on December 12th, 2018, they have entered into a partnership agreement to offer affordable and flexible employee benefit plans and advice as part of LSO’s benefits of membership and available resources. Employee…
News
TORONTO– LSO today announced the recipients of its 2019 LSO Awards, recognizing outstanding individuals and companies contributing to the success of Ontario’s life sciences sector. The awards will be presented during LSO’s Celebration of Success Awards Dinner at Toronto’s Liberty Grand, February 27, 2019. The 2019 awardees are as follows:…
Toronto, ON – On September 10th, 2018, Life Sciences Ontario hosted a roundtable discussion with the Minister of Innovation, Science and Economic Development, Navdeep Bains, and Mississauga Mayor Bonnie Crombie, along with key industry partners from the life sciences sector. The session, held at JLABS in MaRS, was led by…
The Progressive Conservatives’ landslide victory in last week’s provincial election has many of us wondering what’s next. Can this historic shift in power bring social and fiscal policies into balance, or will it trigger an extreme swing of the pendulum? And what does this all mean for our life sciences…
At the opening of Toronto Health Innovation Week this spring, MaRS Discovery District CEO Yung Wu had this to say about our health and life sciences ecosystem: “We have been through crawling and walking, now we are starting to run and sprint.” Indeed, 2018 represents a crossroads for our sector….
PARIS — Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. The investment bolsters the company’s Canadian operations and its commitment to advancing public health around the world. The announcement will be made…
Life Sciences Ontario welcomes the provincial budget released yesterday, including key investments in post-secondary education, healthcare system innovation, and leveraging our ability to attract and retain investment in Ontario’s life sciences sector. The provincial government’s commitment of $50 million for a dedicated life sciences venture fund demonstrates this recognition of our sector…
2017 was a year of paradox for Ontario’s life sciences sector. We encountered significant roadblocks but we also experienced a surge of momentum. There is a sense of optimism regarding the future of life sciences in Ontario, but an equal sense that there is much work still to be done….
New financial contribution will bring total IRAP conditional funding support to $1.48 million December 12, 2016 GUELPH, Ont., CANADA— PlantForm Corporation is advancing its work on innovative antibody treatments for human immunodeficiency virus (HIV) with a financial contribution of up to $117,400 and technical and business advisory services from the…
Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent. Taking a page from United States President Donald Trump, Prime Minister Justin Trudeau’s government has adopted a reductive, fair-means-cheap pricing equation. The effects may be damaging…